mumbai share sun pharmaceut industri ltd drop much 636 bse thursday us drug regul issu import alert karkhadi plant gujarat ban shipment factori make pharma ingredi formul us market
thi factori near vadodara gujarat make small quantiti antibiot got import alert thursday said person sun pharma familiar develop revenu impact veri neglig
fall low bse share close 503 lower day exchang benchmark sensex fell 037 var googletag googletag googletagcmd googletagcmd googletagcmdpushfunct googletagdefineslot3106570lm_wap_ebda_test_middle_300x250_1 300 250 336 280 fluid divgptad15385439327120addservicegoogletagpubad googletagpubadsenablesinglerequest googletagenableservic ifisdeviceenabledsmal googletagcmdpushfunct googletagdisplaydivgptad15385439327120
contribut karkhadi facil near vadodara sun pharma consolid revenu neglig drug maker maintain 201314 fiscal consolid sale growth forecast sun pharma spokesman said statement
compani remain fulli commit complianc ha alreadi initi sever correct step address observ made us fda food drug administr spokesperson said
sun pharma manufactur activ pharma ingredi formul karkhadi unit drug maker oper 12 us three india one canada israel hungri ha suffici manufactur capac serv export var googletag googletag googletagcmd googletagcmd googletagcmdpushfunct googletagdefineslot3106570lm_wap_story_bottom1_multis 300 250 336 280fluid divgptad15215374477113addservicegoogletagpubad googletagpubadsenablesinglerequest googletagenableservic ifisdeviceenabledsmal googletagcmdpushfunct googletagdisplaydivgptad15215374477113
thu compani ha well diversifi manufactur infrastructur cater us market contribut around 54 sale said sector analyst sarabjit kour nangra angel broke ltd
sun pharma subsidiari includ taro pharmaceut industri ltd caraco pharmaceut laboratori ltd recent acquir pharmaceut inc among current account major chunk sale growth
estim impact import alert sun pharma karkhadi plant less 1 sun total sale said sector analyst barclay secur india pvt var googletag googletag googletagcmd googletagcmd googletagcmdpushfunct googletagdefineslot3106570lm_wap_story_bottom3_multis 300 250 336 280fluid divgptad15259314133441addservicegoogletagpubad googletagpubadsenablesinglerequest googletagenableservic ifisdeviceenabledsmal googletagcmdpushfunct googletagdisplaydivgptad15259314133441
howev note sun premium valuat yield limit downsid support oper risk becom
fda alert sun pharma karkhadi plant wa followup observ last inspect regul decemb relat noncompli current good manufactur practic
sun pharma resolv much larger issu similar natur us factori belong subsidiari caraco 2013 nearli sixyear long complianc exercis first fda action face india sever year
us regul ha expand inspect network india ad peopl team also initi surpris inspect issu import alert least half dozen drug manufactur unit last coupl year
india largest drug maker ranbaxi laboratori ltd ha worst hit fda action recent past us drug regul ban formul unit activ ingredi factori toansa last seven month
ranbaxi sign consent decre us drug regul becom compliant qualiti regul two larger indian factori locat pradesh madhya pradesh respect import ban sinc 2008
also paid penalti 500 million us depart justic 2012 compani wa charg fabric document sell drug american market ranbaxi ha lost nearli 1 billion us busi annual sinc 2010 becaus regulatori issu
